Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin.
Gebicki J, Sysa-Jedrzejowska A, Adamus J, Woźniacka A, Rybak M, Zielonka J. Gebicki J, et al. Among authors: wozniacka a. Pol J Pharmacol. 2003 Jan-Feb;55(1):109-12. Pol J Pharmacol. 2003. PMID: 12856834
Topical application of NADH for the treatment of rosacea and contact dermatitis.
Woźniacka A, Sysa-Jedrzejowska A, Adamus J, Gebicki J. Woźniacka A, et al. Clin Exp Dermatol. 2003 Jan;28(1):61-3. doi: 10.1046/j.1365-2230.2003.01118.x. Clin Exp Dermatol. 2003. PMID: 12558633
Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study.
Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Wozniacka A, et al. Clin Exp Dermatol. 2005 Nov;30(6):632-5. doi: 10.1111/j.1365-2230.2005.01908.x. Clin Exp Dermatol. 2005. PMID: 16197374
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
Wozniacka A, Cygankiewicz I, Chudzik M, Sysa-Jedrzejowska A, Wranicz JK. Wozniacka A, et al. Lupus. 2006;15(8):521-5. doi: 10.1191/0961203306lu2345oa. Lupus. 2006. PMID: 16942005
In search for new antipsoriatic agents: NAD topical composition.
Wozniacka A, Szajerski P, Adamus J, Gebicki J, Sysa-Jedrzejowska A. Wozniacka A, et al. Skin Pharmacol Physiol. 2007;20(1):37-42. doi: 10.1159/000096170. Epub 2006 Oct 11. Skin Pharmacol Physiol. 2007. PMID: 17035720 Clinical Trial.
Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A, Narbutt J, Sysa-Jedrzejowska A, Lukamowicz J, McCauliffe DP, Wózniacka A. Lesiak A, et al. Among authors: wozniacka a. Lupus. 2010 May;19(6):683-8. doi: 10.1177/0961203309356455. Epub 2010 Jan 11. Lupus. 2010. PMID: 20064914
Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation.
Narbutt J, Lesiak A, Skibinska M, Wozniacka A, van Loveren H, Sysa-Jedrzejowska A, Lewy-Trenda I, Omulecka A, Norval M. Narbutt J, et al. Among authors: wozniacka a. Photochem Photobiol Sci. 2005 Jul;4(7):517-22. doi: 10.1039/b503166d. Epub 2005 Jun 15. Photochem Photobiol Sci. 2005. PMID: 15986059
Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A. Waszczykowska E, et al. Among authors: wozniacka a. Mediators Inflamm. 1999;8(2):93-100. doi: 10.1080/09629359990586. Mediators Inflamm. 1999. PMID: 10704146 Free PMC article.
Pneumocystis carinii mimicking neonatal lupus erythematosus-related pneumonitis.
Wozniacka A, Robak E, Sysa-Jedrzejowska A, McCauliffe DP. Wozniacka A, et al. Pediatr Dermatol. 2003 Nov-Dec;20(6):524-8. doi: 10.1111/j.1525-1470.2003.20615.x. Pediatr Dermatol. 2003. PMID: 14651575
Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.
Urbańska-Ryś H, Robak E, Kordek R, Bartkowiak J, Rieske P, Woźniacka A, Smolewski P, Robak T. Urbańska-Ryś H, et al. Among authors: wozniacka a. Leuk Lymphoma. 2004 Sep;45(9):1913-8. doi: 10.1080/10428190410001663581. Leuk Lymphoma. 2004. PMID: 15223654
133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback